2026 National Rare Hematology Summit, Cleveland conference hero image

2026 National Rare Hematology Summit, Cleveland

Accreditation: 9.25 Nursing Contact Hours | 9.25 ABIM MOC II | 9.25 AMA PRA Category 1 Credit™ | 9.25 ACPE Pharmacy

Venue: Crowne Plaza Cleveland at Playhouse Square, 1260 Euclid Avenue, Cleveland, OH, United States

Start Date: End Date:
Register for Conference

Official conference page for 2026 National Rare Hematology Summit, Cleveland.

About 2026 National Rare Hematology Summit, Cleveland

Conference
Conference attendees

Overview

Trusted by Thousands of Attendees
Across Our Events

Casandra Calabrese
38+

Faculty and committee

Our Speakers

Conference program and agenda

Our Agenda

Day 1: Friday, August 7th, 2026

All timings are in Central Time (CDT, GMT-05:00) time.

01:00 PM - 02:00 PMRegistration, Welcome Coffee, & Networking
02:00 PM - 02:15 PMWelcome and Opening Remarks
02:15 PM - 03:15 PMSession 1: Clonal Hematopoiesis of Indeterminate Potential (CHIP): Clinical Implications and Evolving Evidence

Session Chair: Uma M Borate, MD; Abhay Singh, MD, MPH

02:15 PM - 02:30 PM

Pathogenesis and Risk Stratification Zoey Xie, MD, MS

02:30 PM - 02:45 PM

Relationship with Hematologic Malignancies and Cardiovascular Disease Ohad Oren, MD

02:45 PM - 03:00 PM

Clinical Monitoring and Management Strategies Namrata Chandhok, MD

03:00 PM - 03:15 PM

Q&A

Moderators:

Abhay Singh, MD, MPH; Uma M Borate, MD

Panelists:

Zoey Xie, MD, MS; Ohad Oren, MD; Namrata Chandhok, MD

03:15 PM - 03:45 PMBreak & Exhibits
03:45 PM - 04:45 PMSession 2: Castleman Disease and Related Lymphoproliferative Disorders: Diagnostic and Therapeutic Updates

Session Chair: Gordon Srkalovic, MD

03:45 PM - 03:55 PM

Classification and Diagnostic Criteria Joshua Daniel Brandstadter, MD PhD

03:55 PM - 04:05 PM

HHV-8 Positive vs Idiopathic Castleman Disease Kathryn Lurain, MD, MPH

04:05 PM - 04:15 PM

Emerging Treatment Options and Ongoing Trials Sudipto Mukherjee, MD, PhD, MPH

04:15 PM - 04:20 PM

Case Presentation Rafaella Litvin, MD

04:20 PM - 04:45 PM

Case-Based Discussion

Moderators:

Gordon Srkalovic, MD

Panelists:

Joshua Daniel Brandstadter, MD PhD; Kathryn Lurain, MD, MPH; Sudipto Mukherjee, MD, PhD, MPH

04:45 PM - 06:00 PMSession 3: Rare Myeloid Disorders: From HES to Mastocytosis

04:45 PM - 05:00 PM

Molecular Profiling and Diagnostic Advances David Bosler, MD

05:00 PM - 05:15 PM

Management of HES Princess Ogbogu, MD

05:15 PM - 05:30 PM

Therapies in Indolent and Aggressive Mastocytosis Pankit J Vachhani, MD

05:30 PM - 05:35 PM

Case Presentation Akriti G Jain, MD

05:35 PM - 06:00 PM

Case-Based Discussion

Moderators:

Daniel DeAngelo, MD, PhD

Panelists:

Princess Ogbogu, MD; David Bosler, MD; Pankit J Vachhani, MD

Day 2: Saturday, August 8th, 2026

07:00 AM - 08:00 AMRegistration, Breakfast, & Networking
08:00 AM - 08:20 AMBinaytara's Efforts in Improving Cancer Care Disparities (non-CME accredited) - Dr. Binay Shah, MD, MHA
08:20 AM - 09:20 AMSession 4: Uncommon Lymphoid Malignancies: Beyond the Standard B- and T-Cell Subtypes

Session Chair: Deepa Jagadeesh, MD

08:20 AM - 08:35 AM

Peripheral T-Cell Lymphoma Variants Yumeng Zhang, MD

08:35 AM - 08:50 AM

NK/T-Cell Lymphoma, Angioimmunoblastic T-Cell Lymphoma Deepa Jagadeesh, MD

08:50 AM - 09:05 AM

Targeted Therapy and Clinical Trials Landscape Taylor Brooks, MD

09:05 AM - 09:20 AM

Panel Discussion

Moderators:

Deepa Jagadeesh, MD

Panelists:

Yumeng Zhang, MD

09:20 AM - 10:20 AMSession 5: Rare Bleeding and Platelet Function Disorders: Practical Management Approaches

Session Chair: Rakhi Naik, MD

09:20 AM - 09:40 AM

Von Willebrand Variants, Platelet Storage Pool Deficiency, Glanzmann's Thrombasthenia Rakhi Naik, MD

09:40 AM - 10:00 AM

Autoimmune Hemolytic Anemias / Laboratory Diagnosis and Management Rules

10:00 AM - 10:05 AM

Case Presentation

10:05 AM - 10:20 AM

Case-Based Discussion

10:20 AM - 10:50 AMBreak & Exhibits (non-CME accredited)
10:50 AM - 11:50 AMSession 6: Hemophagocytic Lymphohistiocytosis (HLH) and Other Hyperinflammatory Syndromes

Session Chair: Daniella Schwartz, MD

10:50 AM - 11:00 AM

Diagnosis and Management of Macrophage Activating Syndrome Casandra Calabrese, DO

11:00 AM - 11:10 AM

HLH in Malignancy and Infections

11:10 AM - 11:20 AM

Evolving Treatment Protocols and Outcomes

11:20 AM - 11:25 AM

Case Presentation Sandra Mazzoni, DO

11:25 AM - 11:50 AM

Case-Based Discussion

Moderators:

Daniella Schwartz, MD

Panelists:

Casandra Calabrese, DO

Venue and map

Accreditations and continuing education

Registration and pricing

Exhibitors and sponsorship